Details for 2016191716

Up to date per 02.04.2026

Actions

Title / Product Name

N-((4,6-DIMETHYL-2-OXO-L,2-DIHYDROPYRIDIN-3-YL)METHYL)-5-(ETHYL (TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-METHYL-4'-(MORPHOLINOMETHYL)-[L,1'-BIPHENYL]-3-CARBOXAMIDE HYDROBROMIDE ZUR VERWENDUNG IN DER BEHANDLUNG EINER ZELLPROLIFERATIVEN KRANKHEIT DES HÄMATOLOGISCHEN SYSTEMS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016191716

EP Publication Number

3184523

E-Number

1145340

Language

PCT Number

Publication Date

28.06.2017 A

19.06.2019 B1

Registration Date

19.06.2019

AT Publication Date

15.07.2019

Application Date

11.04.2013

Registration Number

Priorities

13.04.2012

201261624215 P

IPC

C07D 405/12 20060101AFI20170406BHEP

Maximum Duration of Protection

11.04.2033

Owner

Epizyme Inc400 Technology Square, 4th Floor Cambridge, MA 02139US

Eisai R&D Management Co., Ltd.6-10, Koishikawa-4-chome Bunkyo-ku Tokyo 112-8088JP

Representative

Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

KUNTZ, Kevin Wayne8 New Village Road Woburn, MA Massachusetts 01801US

HUANG, Kuan-chunc/o Eisai 4 Corporate Drive Andover, MA Massachusetts 01810US

CHOI, Hyeong Wookc/o Eisai 4 Corporate Drive Andover, 01810US

SANDERS, Kristenc/o Eisai 4 Corporate Drive Andover, MA Massachusetts 01810US

MATHIEU, Stevenc/o Eisai 4 Corporate Drive Andover, MA Massachusetts 01810US

CHANDA, Aranic/o Eisai 4 Corporate Drive Andover, MA Massachusetts 01810US

FANG, Frankc/o Eisai 4 Corporate Drive Andover, MA Massachusetts 01810US

Information about Fees